Results of Surgical Treatment for Non-Small Cell Lung Cancer of 20 mm or Less in Diameter

Abstract

Background: Surgical efficacy is still unsatisfactory for small lung cancer; accordingly, minimal resection has recently been the focus of increased study. The objective of the current study was to evaluate the factors associated with small lung cancer, and to determine whether such factors are reliable predictors of long-term survival. Methods: We retrospectively investigated 130 patients with histologically confirmed non-small cell carcinoma, whose treatments were primarily surgical, with no chemotherapy or radiotherapy prior to surgery. All tumors were located peripherally and were less than 20 mm in diameter. Follow-up was performed for five-year and eight-year survivors and multivariate analysis with Cox's proportional hazards regression model was performed. Results: Of all 130 patients, the 5-year survival rate among patients with tumors less than 15 mm was 82.5 %, vs. 57.4 % of patients with tumors with a diameter of 16 - 20 mm. The 5-year survival rate of patients who were node negative was 73.9 % while it was 28.5 % for node-positive patients. Status of nodal invasion was also significantly associated with survival in small-size tumors (p < 0.0001). Furthermore, the 5-year survival rate among patients with pleural involvement was 55 % vs. 83.8 % for patients without pleural involvement. Using multivariate Cox analysis, lymph node involvement (p = 0.0004), size (p = 0.0475), and pleural invasion (p = 0.0482) were found to be independent prognostic factors in cases of tumors 20 mm or less in diameter. Conclusions: The results of this study at least demonstrate that the optimal therapy for patients with nodal involvement or patients with tumors of 16 - 20 mm must be carefully determined even in cases of small lung cancer.

References

• 1 Rena O, Oliaro A, Cavallo A, Filosso P L, Donati G, Mariio P D, Maggi G, Ruffini E. Stage I non-small cell lung carcinoma: really an early stage?.  Eur J Cardiothorac Surg. 2002;  21 514-519
• 2 Mountain C F. Revisions in the international system for staging lung cancer.  Chest. 1997;  111 1710-1717
• 3 Riquet M, Monac'h D, Le Pimpec Barthes F, Dujon A, Debrosse D, Debesse B. Prognostic value of T and N in non small cell lung cancer three centimeters or less in diameter.  Eur J Cardiothorac Surg. 1997;  11 440-444
• 4 Nesbitt J C, Patnam J B, Walsh G L, Roth J A, Mountain C F. Survival in early stage non-small cell lung cancer.  Ann Thorac Surg. 1995;  60 466-472
• 5 Thomas P, Doddoli C, Yena S, Thirion X, Sebag F, Fuentes P, Giudicelli R. VATS is adequate oncological operation for stage I non-small cell lung cancer.  Eur J Cardiothorac Surg. 2002;  21 1094-1099
• 6 Bando T, Yamagihara Y, Ohtake Y, Miyahara R, Tanaka F, Hasegawa S, Inui K, Wada H. A new method of segmental resection for primary lung cancer: intermediate result.  Eur J Cardiothorac Surg. 2002;  21 894-899
• 7 Yoshikawa K, Tsubota N, Kodama Ayabe K H, Taki T, Mori T. For the study group of extended segmentectomy for small lung tumors. Prospective study of extended segmentectomy for small lung tumors: the final report.  Ann Thorac Surg. 2002;  73 1055-1059
• 8 Noguchi M, Morikawa A, Kawasaki M, Matsuno Y, Yamada T, Hirohashi S, Kondo H, Shimosato Y. Small adenocarcinoma of the lung.  Cancer. 1955;  75 2844-2852
• 9 Rena O, Papalia E, Ruffini E, Casadio C, Filosso P L, Oliaro A, Maggi G. Stage I pure bronchoalveolar carcinoma: recurrences, survival and comparison with adenocarcinoma of the lung.  Eur J Cardiothorac Surg. 2003;  23 409-414
• 10 Daniels L J, Balderson S S, PA-C, Onaitis M W, D'Amico T A. Thoracoscopic lobectomy: A safe and effective strategy for patients with stage I lung cancer.  Ann Thorac Surg. 2002;  74 860-864
• 11 David R J, Brendon M S, Chadrick E D, Philip A, and Thomas M D. Pulmonary segmentectomy: Results and complications.  Ann Thorac Surg. 2003;  76 343-349
• 12 Ishida T, Yano T, Maeda K, Kaneko S, Tateshi M, Sugimachi K. Strategy for lymphadenectomy in lung cancer three centimeters or less in diameter.  Ann Thorac Surg. 1990;  50 708-713
• 13 Miller D L, Rowland C M, Deschamps C, Allen M S, Trastek V F, Pairolero P C. Surgical treatment of non-small cell lung cancer 1 cm or less in diameter.  Ann Thorac Surg. 2002;  73 1545-1551
• 14 Melfi F M, Chella A, Menconi G F, Givigliano F, Boni G, Mariani G, Sbragia P, Angeletti C A. Intraoperative radioguided sentinel lymph node biopsy in non-small cell lung cancer.  Eur J Cardiothorac Surg. 2003;  23 214-220
• 15 Nakagawa T, Minamiya Y, Katayose Y, Saito H, Taguchi K, Imano H, Watanabe H, Enomoto K, Sageshima M, Ueda T, Ogawa J. A novel method for sentinel lymph node mapping using magnetite in patients with non-small cell lung cancer.  J Thorac Cardiovasc Surg. 2003;  126 563-567
• 16 Buhr J, Berghauser K H, Gonner S, Kelm C, Burkhardt E A, Padbery W M. The prognostic significance of tumor cell detection intraoperative pleural lavage and lung tissue cultures for patient with lung cancer.  J Thorac Cardiovasc Surg. 1997;  113 683-690
• 17 Macchiarini P, Fontanini G, Hardin M J. Blood vessel invasion by tumor cells predicts recurrence in completely resected T1N0M0 non-small lung cancer.  J Thorac Cardiovasc Surg. 1993;  106 80-89
• 18 Suzuki K, Nagai K, Yoshida J, Nishimura M, Nishiwaki Y. Predictors of lymph node and intrapulmonary metastasis in stage I. A non-small cell lung carcinoma.  Ann Thorac Surg. 2001;  72 352-356